Guidelines for Evaluating Hematochezia in Adults Near Colorectal‑Cancer Screening Age

1. Interpretation of Bleeding Characteristics

Bright red, fresh blood on the toilet paper or dripping into the bowl strongly suggests a lower gastrointestinal or anorectal source (e.g., hemorrhoids or anal fissure), whereas dark‑red or maroon blood mixed throughout the stool points to a more proximal colonic or upper‑GI lesion. 1
The presence of blood mixed uniformly with stool should raise suspicion for proximal pathology and prompt early endoscopic evaluation. 1

Lightheadedness, syncope, or presyncope in a patient with hematochezia signals hemodynamic compromise and mandates immediate resuscitation and urgent investigation. 4
Ongoing active bleeding observed in the emergency department indicates the need for rapid diagnostic imaging or endoscopy to locate the source. 5
A history of prior blood‑product transfusion for gastrointestinal bleeding is an objective marker of severe hemorrhage and influences triage decisions. 4

Post‑defecatory abdominal pain is characteristic of an anal fissure and helps differentiate fissure‑related bleeding from other causes. 2
New‑onset changes in bowel habit (new constipation or diarrhea) in individuals older than 45 years are red‑flag features for colorectal neoplasia and should trigger colonoscopic assessment. 6
Unintentional weight loss in the setting of rectal bleeding raises concern for malignancy or inflammatory bowel disease and warrants comprehensive work‑up. 6
Tenesmus or a sensation of incomplete evacuation may indicate a rectal mass or active inflammatory process and should be investigated endoscopically. 6

Use of antiplatelet agents (e.g., aspirin, clopidogrel) or anticoagulants (warfarin, DOACs) increases the likelihood of significant bleeding and can unmask underlying lesions; medication review is essential. 4
Chronic alcohol consumption is a risk factor for portal hypertension and variceal formation, which can present as brisk rectal bleeding. 1

A first‑degree relative with colorectal cancer or advanced adenoma diagnosed before age 60 markedly elevates the patient’s risk and influences the decision to proceed directly to colonoscopy. 8
Personal history of colorectal polyps, inflammatory bowel disease, or prior colorectal cancer constitutes a high‑risk profile that mandates surveillance colonoscopy. 8
In patients around 47 years of age, any new‑onset hematochezia warrants colonoscopic evaluation regardless of presumed hemorrhoidal origin. 7

Approximately 10–15 % of patients presenting with hematochezia have an upper‑GI source; clinicians should maintain a high index of suspicion. 9
A prior history of peptic ulcer disease or chronic gastritis suggests that the bleeding may originate from the upper gastrointestinal tract. 9
Portal hypertension or advanced liver disease can produce variceal bleeding that manifests as bright rectal bleeding. 1
An elevated blood urea nitrogen (BUN) level is a laboratory clue indicating digested blood from an upper‑GI bleed. 5
The presence of hematemesis or coffee‑ground emesis definitively confirms an upper‑GI source. 9

The timing and persistence of prolapsing perianal tissue (only during defecation vs. persistent) help grade hemorrhoid severity and guide management. 8
Acute, severe perianal pain is typical of a thrombosed external hemorrhoid, whereas pain that occurs only with defecation points toward an anal fissure. 3
Pruritus and mucus discharge are common accompanying symptoms of prolapsing hemorrhoids but may also result from poor hygiene or minor incontinence. 2
A palpable perianal lump requires differentiation between a thrombosed hemorrhoid, perianal abscess, or other mass lesions. 3

Clinicians should not attribute rectal bleeding solely to hemorrhoids based on history; in patients approaching the colorectal‑cancer screening threshold, colonoscopy is recommended for any episode of hematochezia to exclude serious pathology. 8